PlainPharmaWatch

CMS Open Payments · Tool

CONMED Corporation vs Harrow Eye, LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Harrow Eye, LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 621, versus 586 for the other company. Its single largest recorded recipient represents 0.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

CONMED Corporation
HHI 586 · top recipient 0.1%
Ranked #1,238 of 1,838 companies by HHI
Harrow Eye, LLC
HHI 621 · top recipient 0.2%
Ranked #1,225 of 1,838 companies by HHI

Payment Overview

Company A

CONMED Corporation

Total Payments
$1.1M
% of Industry
0.0%
Transactions
3,574
Avg per Transaction
$306.48
Recipients
3,570
Avg per Recipient
$306.83
Payment Types
10
Top Payment Type
Food and Beverage
Company B

Harrow Eye, LLC

Total Payments
$1.1M
% of Industry
0.0%
Transactions
11,566
Avg per Transaction
$94.66
Recipients
11,566
Avg per Recipient
$94.66
Payment Types
6
Top Payment Type
Food and Beverage

Highlighted values indicate the higher figure for each metric.

Total payments compared

CONMED Corporation vs Harrow Eye, LLC - total reported payments in CMS Open Payments PY2024

CONMED Corporation$1.1MHarrow Eye, LLC$1.1M

Payment Types Breakdown

CONMED Corporation

Food and Beverage $167.1K

15.3%

Consulting Fee $159.3K

14.5%

Space Rental or Facility Fees $155.6K

14.2%

Travel and Lodging $127.8K

11.7%

Debt Forgiveness $99.6K

9.1%

Royalty or License $95.8K

8.7%

Harrow Eye, LLC

Food and Beverage $385.5K

35.2%

Honoraria $219.5K

20.0%

Compensation for Services Other Than Consulting $189.7K

17.3%

Grant $150.0K

13.7%

Consulting Fee $110.6K

10.1%

Travel and Lodging $39.5K

3.6%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

CONMED Corporation

  1. 1

    MICHAEL HARKINS

    $126,083.33 · 91 txns

  2. 2

    UNIVERSITY OF CO HOSPITAL

    $121,775.00 · 6 txns

  3. 3

    NAOMI L NAKAO

    $118,976.93 · 11 txns

  4. 4

    PALMETTO GENERAL HOSPITAL

    $49,536.96 · 1 txns

  5. 5

    WADLEY REGIONAL MEDICAL CENTER

    $27,816.99 · 1 txns

Harrow Eye, LLC

  1. 1

    RICHARD ADLER

    $196,760.60 · 103 txns

  2. 2

    UDAY DEVGAN

    $150,000.00 · 4 txns

  3. 3

    MARTIN MAKARY

    $90,357.05 · 8 txns

  4. 4

    PAUL KARPECKI

    $42,416.60 · 18 txns

  5. 5

    RANJAN MALHOTRA

    $31,523.37 · 33 txns

Summary Comparison

Metric CONMED Corporation Harrow Eye, LLC
Total Payments $1.1M $1.1M
% of Industry Total 0.0% 0.0%
Transaction Count 3,574 11,566
Avg per Transaction $306.48 $94.66
Recipient Count 3,570 11,566
Avg per Recipient $306.83 $94.66
Payment Type Count 10 6
Top Payment Type Food and Beverage Food and Beverage

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.